Amnon Gonenne
Chief Executive Officer at Immunotherapy Corp.
Profile
Amnon Gonenne is currently the Chief Executive Officer at Immunotherapy Corp.
Prior to this, he worked as a Director at MabCure, Inc. from 2008 to 2012.
He holds a doctorate degree from Syracuse University.
Amnon Gonenne active positions
| Companies | Position | Start |
|---|---|---|
Immunotherapy Corp.
 Immunotherapy Corp. Pharmaceuticals: OtherHealth Technology Part of Sarepta Therapeutics, Inc., Immunotherapy Corp. develops cancer treatments. The company is based in Seattle, WA. The CEO of the company is Amnon Gonenne. Immunotherapy was acquired by AntiVirals, Inc. on November 06, 1997 for $24 million. | Chief Executive Officer | 30/11/2009 |
Former positions of Amnon Gonenne
| Companies | Position | End |
|---|---|---|
| MABCURE INC | Director/Board Member | 12/11/2012 |
Training of Amnon Gonenne
| Syracuse University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MABCURE INC | Health Technology |
| Private companies | 1 |
|---|---|
Immunotherapy Corp.
Immunotherapy Corp. Pharmaceuticals: OtherHealth Technology Part of Sarepta Therapeutics, Inc., Immunotherapy Corp. develops cancer treatments. The company is based in Seattle, WA. The CEO of the company is Amnon Gonenne. Immunotherapy was acquired by AntiVirals, Inc. on November 06, 1997 for $24 million. | Health Technology |
- Stock Market
- Insiders
- Amnon Gonenne
